Figure 2.
Modified Rankin Scale (mRS) scores at 90 d. A, First cohort (March 2014 to June 2016, n=1488) vs second cohort of the MR CLEAN Registry (June 2016 to November 2017, n=1692). Shift toward better functional outcomes in cohort 2 (age and sex adjusted common odds ratio [acOR], 1.26 [95% CI, 1.11–1.43]). B, Outcomes per chronological quartile of treated patients over time (Q1 n=795, Q2 n=797, Q3 n=793, Q4 n=795; age and sex adjusted acOR, 1.13 [95% CI, 1.06–1.19]). Q indicates quartile.
